Source: International Congress 2014 – ILDs 6
Disease area: Airway diseases, Interstitial lung diseases

Abstract

Interstitial fibrosis with emphysema [also called smoking-related interstitial fibrosis (SRIF), or airspace enlargement with fibrosis] is increasingly recognised, described with co-existing lung cancer.



.We undertook a prospective clinical, radiological and pathological analysis of non-cancerous lung from lung cancer resections (n=20), assessing smoking history, fibrosis and small airway changes by histology (see Katzeinstein AL et al 2010) and by protocol-derived high resolution CT (HRCT).Histological emphysema-associated interstitial fibrosis (SRIF) was found in 40%, distant to the lung cancer and associated with small airway changes.Gender and age distribution was similar in both SRIF and non-SRIF subjects, with SRIF observed in 87.5% in the right lung, (62.5% in the right upper lobe), and associated with decreased forced expiratory volume in 1 second (p=0.0026). In all, SRIF had no HRCT correlate.We assessed the histological findings in explanted lungs from radiologic emphysema subjects [n=20 chronic obstructive pulmonary disease (COPD), mean cigarette pack-years (PY)=45; n=20 alpha 1-antitrypsin deficiency (A1AT), mean PY=25]; SRIF was observed in 40% of COPD and 25% of A1AT (linear correlation with mean PY).In summary, histologic fibrosis with emphysema is radiologically occult, highly prevalent, with a dose-response relationship to smoking, and independent of the cancer in the nearby lung.

Rating:

Share or cite this content

Citations should be made in the following way:
A. Fabre, N. Faheem, J. Dodd, M. Narski, A. Treacy, D. Healy, I. Lawrie, T. Finucane, M. Keane, J. Egan, M. Tolan, G. Jebrak, H. Mal, M. Butler (Dublin, Ireland; Paris, France). Fibrosis in emphysema: Radiologically occult but histologically prevalent process proportionate to smoking burden. Eur Respir J 2014; 44: Suppl. 58, 3800

Member's Comments

No comment yet.

Related content which might interest you: Impact of smoking habit on lung function in a large cohort sarcoidosis patients. Source: International Congress 2014 – Sarcoidosis Year: 2014 Injury and repair responses of parenchymal fibroblasts in advanced chronic obstructive pulmonary disease Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 LSC 2014 abstract - Influenza infection may cause exacerbation of lung fibrosis through collagen deposition Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Vascular endothelialgrowth factor of poor prognosis of a new form of bronchopulmonary dysplasia Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Differential function of IL-17A in cigarette smoke induced lung damage Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Pregnancy course in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Proteasome function in pulmonary fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary? Source: International Congress 2014 – ILDs 4 Year: 2014 Remodeling of bronchial and pulmonary muscular arteries in mild/moderate COPD Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Reduction in disease progression with nintedanib in the INPULSIS™ trials Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Comorbidities associated with sarcoidosis – Results from long-term observational study Source: International Congress 2014 – Sarcoidosis Year: 2014 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Functional and molecular disparities between mesenchymal stem cells from various pulmonary disorders Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 IL-22 exacerbates pulmonary inflammation in mice after acute exposure of cigarette smoke Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Abnormal respiratory epithelial repair in chronic obstructive pulmonary disease Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients Source: International Congress 2014 – Sarcoidosis Year: 2014 Cognitive failure in sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation Year: 2020